Literature DB >> 20801194

Complex role of zinc in methamphetamine toxicity in vitro.

E Aizenman1, M C McCord, R A Saadi, K A Hartnett, K He.   

Abstract

Methamphetamine is a drug of abuse that can induce oxidative stress and neurotoxicity to dopaminergic neurons. We have previously reported that oxidative stress promotes the liberation of intracellular Zn(2+) from metal-binding proteins, which, in turn, can initiate neuronal injurious signaling processes. Here, we report that methamphetamine mobilizes Zn(2+) in catecholaminergic rat pheochromocytoma (PC12) cells, as measured by an increase in Zn(2+)-regulated gene expression driven by the metal response element transcription factor-1. Moreover, methamphetamine-liberated Zn(2+) was responsible for a pronounced enhancement in voltage-dependent K(+) currents in these cells, a process that normally accompanies Zn(2+)-dependent cell injury. Overnight exposure to methamphetamine induced PC12 cell death. This toxicity could be prevented by the cell-permeant zinc chelator N,N,N', N'-tetrakis(2-pyridylmethyl)-ethylenediamine (TPEN), and by over-expression of the Zn(2+)-binding protein metallothionein 3 (MT3), but not by tricine, an extracellular Zn(2+) chelator. The toxicity of methamphetamine to PC12 cells was enhanced by the presence of co-cultured microglia. Remarkably, under these conditions, TPEN no longer protected but, in fact, dramatically exacerbated methamphetamine toxicity, tricine again being without effect. Over-expression of MT3 in PC12 cells did not mimic these toxicity-enhancing actions of TPEN, suggesting that the chelator affected microglial function. Interestingly, P2X receptor antagonists reversed the toxicity-enhancing effect of TPEN. As such, endogenous levels of intracellular Zn(2+) may normally interfere with the activation of P2X channels in microglia. We conclude that Zn(2+) plays a significant but complex role in modulating the cellular response of PC12 cells to methamphetamine exposure in both the absence and presence of microglia.
Copyright © 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801194      PMCID: PMC2956874          DOI: 10.1016/j.neuroscience.2010.08.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  52 in total

Review 1.  Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo.

Authors:  F M Hughes; J A Cidlowski
Journal:  Adv Enzyme Regul       Date:  1999

2.  Extensive peroxynitrite activity during progressive stages of central nervous system inflammation.

Authors:  R C van der Veen; D R Hinton; F Incardonna; F M Hofman
Journal:  J Neuroimmunol       Date:  1997-07       Impact factor: 3.478

3.  Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

Authors:  Lin Zhang; Kiyoyuki Kitaichi; Yohei Fujimoto; Hironao Nakayama; Eiji Shimizu; Masaomi Iyo; Kenji Hashimoto
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-07-12       Impact factor: 5.067

4.  Regulation of apoptotic potassium currents by coordinated zinc-dependent signalling.

Authors:  Patrick T Redman; Karen A Hartnett; Mandar A Aras; Edwin S Levitan; Elias Aizenman
Journal:  J Physiol       Date:  2009-07-21       Impact factor: 5.182

5.  Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression.

Authors:  Amornpan Ajjimaporn; Pansiri Phansuwan-Pujito; Manuchair Ebadi; Piyarat Govitrapong
Journal:  Neurosci Lett       Date:  2007-04-19       Impact factor: 3.046

6.  Protein kinase C regulation of neuronal zinc signaling mediates survival during preconditioning.

Authors:  Mandar A Aras; Hirokazu Hara; Karen A Hartnett; Karl Kandler; Elias Aizenman
Journal:  J Neurochem       Date:  2009-04-22       Impact factor: 5.372

7.  Zn2+ regulates Kv2.1 voltage-dependent gating and localization following ischemia.

Authors:  Mandar A Aras; Robert A Saadi; Elias Aizenman
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

8.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

Authors:  J F Cubells; S Rayport; G Rajendran; D Sulzer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

9.  Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades.

Authors:  Subramaniam Jayanthi; Xiaolin Deng; Pierre-Antoine H Noailles; Bruce Ladenheim; Jean Lud Cadet
Journal:  FASEB J       Date:  2004-02       Impact factor: 5.191

10.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

View more
  4 in total

1.  Ca2+ entry pathways in mouse spinal motor neurons in culture following in vitro exposure to methylmercury.

Authors:  Gunasekaran Ramanathan; William D Atchison
Journal:  Neurotoxicology       Date:  2011-08-02       Impact factor: 4.294

Review 2.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

3.  Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway.

Authors:  Vanessa Coelho-Santos; Joana Gonçalves; Carlos Fontes-Ribeiro; Ana Paula Silva
Journal:  J Neuroinflammation       Date:  2012-07-06       Impact factor: 8.322

4.  Toxicity effects of methamphetamine on embryonic stem cell-derived neuron.

Authors:  Rokhsareh Meamar; Leila Dehghani; Freshte Karamali
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.